logo

Celgene Corporation (CELG)



Trade CELG now with
  Date
  Headline
9/12/2018 7:31:38 AM Celgene Reports Results Of Two Post Hoc Sub-analyses Of Clinical Trials For OTEZLA
9/6/2018 1:06:37 AM Evotec, Celgene Enter Long-term Strategic Drug Discovery Development Partnership
7/26/2018 7:31:26 AM Celgene Q2 Total Revenue Up 17% To $3.814 Bln
7/23/2018 4:35:08 PM Clinical: Phase III AUGMENT Study Of REVLIMID In Combination With Rituximab Met Primary Endpoint
7/19/2018 8:31:04 PM WuXi STA And Antengene Sign Development And Manufacturing Deal
7/10/2018 7:33:05 AM Celgene Says Phase III IMpassion130 Study Meets Co-primary Endpoint Of Progression-free Survival
6/19/2018 4:32:03 PM Celgene Appoints Jonathan Biller As EVP And General Counsel
6/3/2018 12:22:39 PM Celgene Updates Data From TRANSCEND Trial Of Liso-cel In Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma